261 related articles for article (PubMed ID: 16979374)
1. Decrease in mast cells in oral squamous cell carcinoma: possible failure in the migration of these cells.
Oliveira-Neto HH; Leite AF; Costa NL; Alencar RC; Lara VS; Silva TA; Leles CR; Mendonça FE; Batista AC
Oral Oncol; 2007 May; 43(5):484-90. PubMed ID: 16979374
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical evaluation of mast cells and angiogenesis in oral squamous cell carcinoma.
Sharma B; Sriram G; Saraswathi TR; Sivapathasundharam B
Indian J Dent Res; 2010; 21(2):260-5. PubMed ID: 20657098
[TBL] [Abstract][Full Text] [Related]
3. Expression of hepatocyte growth factor and c-met protein is significantly associated with the progression of oral squamous cell carcinoma in Taiwan.
Chen YS; Wang JT; Chang YF; Liu BY; Wang YP; Sun A; Chiang CP
J Oral Pathol Med; 2004 Apr; 33(4):209-17. PubMed ID: 15061708
[TBL] [Abstract][Full Text] [Related]
4. Role of TP53 in the progression of pre-malignant and malignant oral mucosal lesions. A follow-up study of 144 patients.
Ogmundsdóttir HM; Björnsson J; Holbrook WP
J Oral Pathol Med; 2009 Aug; 38(7):565-71. PubMed ID: 19473450
[TBL] [Abstract][Full Text] [Related]
5. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings.
Khan Z; Tiwari RP; Mulherkar R; Sah NK; Prasad GB; Shrivastava BR; Bisen PS
Head Neck; 2009 Aug; 31(8):1039-48. PubMed ID: 19340865
[TBL] [Abstract][Full Text] [Related]
6. Dual role of CCL3/CCR1 in oral squamous cell carcinoma: implications in tumor metastasis and local host defense.
Silva TA; Ribeiro FL; Oliveira-Neto HH; Watanabe S; Alencar Rde C; Fukada SY; Cunha FQ; Leles CR; Mendonça EF; Batista AC
Oncol Rep; 2007 Nov; 18(5):1107-13. PubMed ID: 17914560
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of E-cadherin in metastatic lesions comparing to primary oral squamous cell carcinoma.
Hung KF; Chang CS; Liu CJ; Lui MT; Cheng CY; Kao SY
J Oral Pathol Med; 2006 Nov; 35(10):589-94. PubMed ID: 17032390
[TBL] [Abstract][Full Text] [Related]
8. Differential infiltration of CD8+ and NK cells in lip and oral cavity squamous cell carcinoma.
Zancope E; Costa NL; Junqueira-Kipnis AP; Valadares MC; Silva TA; Leles CR; Mendonça EF; Batista AC
J Oral Pathol Med; 2010 Feb; 39(2):162-7. PubMed ID: 19754647
[TBL] [Abstract][Full Text] [Related]
9. Changes in peripheral blood lymphocyte phenotypes distribution in patients with oral cancer/oral leukoplakia in Taiwan.
Lee JJ; Lin CL; Chen TH; Kok SH; Chang MC; Jeng JH
Int J Oral Maxillofac Surg; 2010 Aug; 39(8):806-14. PubMed ID: 20605406
[TBL] [Abstract][Full Text] [Related]
10. Increased Cyfra 21-1 concentration in saliva from primary oral squamous cell carcinoma patients.
Zhong LP; Zhang CP; Zheng JW; Li J; Chen WT; Zhang ZY
Arch Oral Biol; 2007 Nov; 52(11):1079-87. PubMed ID: 17612501
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of SENP5 in oral squamous cell carcinoma and its association with differentiation.
Ding X; Sun J; Wang L; Li G; Shen Y; Zhou X; Chen W
Oncol Rep; 2008 Nov; 20(5):1041-5. PubMed ID: 18949399
[TBL] [Abstract][Full Text] [Related]
12. Langerhans cells and T cells sense cell dysplasia in oral leukoplakias and oral squamous cell carcinomas--evidence for immunosurveillance.
Öhman J; Magnusson B; Telemo E; Jontell M; Hasséus B
Scand J Immunol; 2012 Jul; 76(1):39-48. PubMed ID: 22469080
[TBL] [Abstract][Full Text] [Related]
13. Decreased expression of DARPP-32 in oral premalignant and malignant lesions.
Pimenta FJ; Horta MC; Vidigal PV; De Souza BR; De Marco L; Romano-Silva MA; Gomez RS
Anticancer Res; 2007; 27(4B):2339-43. PubMed ID: 17695523
[TBL] [Abstract][Full Text] [Related]
14. Expression of vascular endothelial growth factor-C does not predict occult lymph-node metastasis in early oral squamous cell carcinoma.
Faustino SE; Oliveira DT; Nonogaki S; Landman G; Carvalho AL; Kowalski LP
Int J Oral Maxillofac Surg; 2008 Apr; 37(4):372-8. PubMed ID: 18295452
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of expression of midkine in oral squamous cell carcinoma and its correlation with tumour angiogenesis.
Ruan M; Ji T; Wu Z; Zhou J; Zhang C
Int J Oral Maxillofac Surg; 2007 Feb; 36(2):159-64. PubMed ID: 17110085
[TBL] [Abstract][Full Text] [Related]
16. Patients with oral cancer developing from pre-existing oral leukoplakia: do they do better than those with de novo oral cancer?
Weijers M; Ten Hove I; Allard RH; Bezemer DP; van der Waal I
J Oral Pathol Med; 2008 Mar; 37(3):134-6. PubMed ID: 18251936
[TBL] [Abstract][Full Text] [Related]
17. Cytokeratin alteration in oral leukoplakia and oral squamous cell carcinoma.
Fillies T; Jogschies M; Kleinheinz J; Brandt B; Joos U; Buerger H
Oncol Rep; 2007 Sep; 18(3):639-43. PubMed ID: 17671713
[TBL] [Abstract][Full Text] [Related]
18. H3 and H3.3 histone mRNA amounts and ratio in oral squamous cell carcinoma and leukoplakia.
Piscopo M; Campisi G; Colella G; Bilancione M; Caccamo S; Di Liberto C; Tartaro GP; Giovannelli L; Pulcrano G; Fucci L
Oral Dis; 2006 Mar; 12(2):130-6. PubMed ID: 16476033
[TBL] [Abstract][Full Text] [Related]
19. Expression of hypoxia-inducible factor-1 alpha is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan.
Lin PY; Yu CH; Wang JT; Chen HH; Cheng SJ; Kuo MY; Chiang CP
J Oral Pathol Med; 2008 Jan; 37(1):18-25. PubMed ID: 18154573
[TBL] [Abstract][Full Text] [Related]
20. Density and migration of mast cells in lip squamous cell carcinoma and actinic cheilitis.
Costa NL; Oton-Leite AF; Cheim-Júnior AP; Alencar Rde C; Bittar GO; Silva TA; Batista AC
Histol Histopathol; 2009 Apr; 24(4):457-65. PubMed ID: 19224448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
